Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus

From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Autores principales: Wong, Karen K., Davey, Richard T., Hewlett, Angela L., Kraft, Colleen S., Mehta, Aneesh K., Mulligan, Mark J., Beck, Allison, Dorman, William, Kratochvil, Christopher J., Lai, Lilin, Palmore, Tara N., Rogers, Susan, Smith, Philip W., Suffredini, Anthony F., Wolcott, Mark, Ströher, Ute, Uyeki, Timothy M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946014/
https://ncbi.nlm.nih.gov/pubmed/27118786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw256
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares